ArticleHuman genomics2026
Prenatal and postnatal manifestations of WBP11-related disorder in Chinese patients: expanding the phenotypic and mutational spectrum.
Article in Human genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundHeterozygous pathogenic variants in WBP11, a spliceosome-associated gene, have recently been linked to VACTERL syndrome, yet prenatal manifestations and genotype–phenotype correlations remain poorly characterized.
methodsGenomic DNA was extracted from fetal tissues, amniotic fluid cells, or peripheral blood samples for trio-based whole-exome sequencing (WES) to identify potential genetic etiologies. The structural stability of the WBP11 protein associated with missense variants was characterized using 3D protein structural modeling. The impact of splicing variant was further evaluated through TA cloning coupled with Sanger sequencing.
resultsHere, we report the first case series of WBP11-related disorder in Chinese patients, comprising four fetuses and one postnatal child from five unrelated families. Whole-exome sequencing identified five previously unreported heterozygous WBP11 variants (NM_016312.3), including three nonsense (p.Arg55*, p.Lys83*, p.Ser279*), one canonical splice-site (c.1310-1G > A), and one missense (p.Arg91Cys). Three occurred de novo, while two were paternally inherited from clinically unaffected or mildly affected carriers, supporting incomplete penetrance. Crucially, RNA analysis of amniocytes carrying the c.1310-1G > A variant revealed only 4% aberrant splicing (c.1310del, p.Gly437Glufs*6), explaining the mild fetal phenotype of isolated femoral shortening and challenging conventional assumptions about the pathogenicity of canonical splice-site variants. The postnatal patient primarily presents with retinal pigmentary degeneration, hearing impairment, bilateral cryptorchidism, short stature, and global developmental delay. Most of these features have been reported in WBP11-related cases but are not considered classic diagnostic criteria for VACTERL. Notably, prenatal cases predominantly presented with cardiac malformations, whereas vertebral anomalies, common postnatally, were absent prenatally, suggesting age-dependent phenotypic evolution.
conclusionsWe have documented the retinal pigment phenotype in WBP11 mutant patients for the first time. Our findings expand the mutational and clinical spectrum of WBP11-related disease, highlight the limitations of sequence-based variant interpretation without functional or transcriptomic validation, and underscore the necessity of integrating detailed phenotypic correlation into prenatal genetic counseling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.